Brian Walsh is a highly skilled sales leader with over 25 years of experience driving growth in CRO/CDMO services and commercial products. His expertise spans the entire drug discovery, development, and manufacturing lifecycle. Before joining OmniaBio, Brian served as SVP of Business Development at Cellipont, where he played a key role in global revenue growth and brand development. Prior to that, as Vice President of Business Development at Abzena, a global biologics CDMO, he expanded the company's biologics services in the U.S. and Asia. Brian began his career in the CRO/CDMO industry in a business development role, eventually advancing to Vice President of Business Development at Aptuit, an integrated discovery, development, and manufacturing organization. There, he was instrumental in rebranding the company's services and driving significant sales and revenue growth worldwide. He has worked for both Bristol-Myers Squibb and Amgen in various sales, marketing and training roles.